Valsartan Recall Cancer Lawsuits
NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.
The medical device manufacturer Stryker announced a voluntary recall of both the ABG II and Rejuvenate hip implants due to potential risks involved with the device’s modular neck-stems. The company says that the device’s stems are at risk of corrosion or fretting, which could manifest as adverse tissue reaction involving intense swelling and/or pain.
Today, thousands of patients have had the device implanted and are now requiring treatment to reduce debilitating symptoms. Some patients have experienced a significant reaction to the device and need revision surgery for a secondary hip replacement. Unfortunately, developing a femur fracture in surgery can happen accidentally during the removal of the existing device, or is the only alternative if the surgeon needs to break the bone to unlock it from its position.